Normalizing Atypical Genitalia: How a Heated Debate Went Astray: How a Heated Debate Went Astray

Hastings Center Report

Volumn 42, Issue 6, 2012, Pages 32-44

  Johnston, Josephine ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; CLITORIS; CONGENITAL ADRENAL HYPERPLASIA; CONGENITAL MALFORMATION; FEMALE; FEMALE CIRCUMCISION; FOOD AND DRUG ADMINISTRATION; GENDER IDENTITY; GONADAL DISEASE; HUMAN; NOMENCLATURE; PATHOLOGY; PLASTIC SURGERY; PSYCHOLOGICAL ASPECT; RESEARCH ETHICS; UNITED STATES;

ADRENAL HYPERPLASIA, CONGENITAL; CIRCUMCISION, FEMALE; CLITORIS; DEXAMETHASONE; ETHICS, RESEARCH; FEMALE; GENDER IDENTITY; GLUCOCORTICOIDS; HUMANS; RECONSTRUCTIVE SURGICAL PROCEDURES; TERMINOLOGY AS TOPIC; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION; VIRILISM;

EID: 84869025223     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1002/hast.82     Document Type: Article

References (67)

1. "Congenital Adrenal Hyperplasia, " PubMedHealth, http://www.ncbi.nlm.nih.gov/pubmedhealth/PMH0001448/.
2. A. Prader, "Der Genitalbefund beim Pseudohermaphroditismus femininus der kengenitalen adrenogenitalen Syndroms, " Helvetica Paediatrica Acta 9, no. 3 (1954): 231-48.
3. P.C. White and P.W. Speiser, "Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency, " Endocrine Reviews 21, no. 3 (2000): 245-91.
4. D.A. Diamond et al., "Not Fetal Cosmetology, " Bioethics Forum, March 8, 2010, http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4528#ixzz1YVLKNiij.
5. P.W Speiser et al., "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society Clinical Practice Guideline, " Journal of Clinical Endocrinology and Metabolism 95, no. 9 (2010): 4133-60.
6. Intersex Society of North America, "Recommendations for Treatment: Intersex Infants and Children, " (San Francisco, Calif.: Intersex Society of North America, 1995).
7. M. Diamond and H.K. Sigmundson, "Management of Intersexuality: Guidelines for Dealing with Individuals with Ambiguous Genitalia, " Archives of Pediatrics and Adolescent Medicine 151 (1997): 1046-50.
8. A.D. Dreger, "'Ambiguous Sex'-or Ambivalent Medicine: Ethical Issues in the Treatment of Intersexuality, " Hastings Center Report 28, no. 3 (1998): 24-35.
9. S. Krege et al., "Long-Term Follow-Up of Female Patients with Congenital Adrenal Hyperplasia from 21-Hydroxylase Deficiency, with Special Emphasis on the Results of Vaginoplasty, " BJU International 86, no. 3 (2000): 253-58
10. L. Rangecroft, on behalf of the British Association of Paediatric Surgeons Working Party on the Surgical Management of Children Born with Ambiguous Genitalia, "Surgical Management of Ambiguous Genitalia, " Archives of Diseases in Childhood 88, no. 9 (2003): 799-801.
11. Consortium on the Management of Disorders of Sex Development, "Clinical Guidelines for the Management of Disorders of Sex Development in Childhood, " Intersex Society of North America, August 16, 2006, http://www.dsdguidelines.org/files/clinical.pdf.
12. See N.S. Crouch et al., "Sexual Function and Genital Sensitivity Following Feminizing Genitoplasty for Congenital Adrenal Hyperplasia, " Journal of Urology 179, no. 2 (2008): 634-38. Regarding the argument that studies such as this, using subjects operated on in the 1980s, cannot speak to current surgical methods, Crouch et al. write, "most clitoral procedures were based on the dorsal neurovascular bundle preservation approach described in 1981 by Mollard, which has become the basis of current practice and has been widely used after 1985. Outcome data on surgery performed in the 1990s will not be available for some years to come when these individuals become sexually active. The current data serve as an important benchmark for future investigations of the effects of newer surgical techniques" (p. 637).
13. S.M. Creighton and L.-M. Liao, "Changing Attitudes to Sex Assignment in Intersex, " BJU International 93 (2004): 659-64.
14. See C. Chase, "Hermaphrodites Speak!" Intersex Society of North America, 1997 (video); A. Dreger, ed., Intersex in the Age of Ethics (Hagerstown, Md.: University Publishing Group, 1999).
15. Consortium on the Management of Disorders of Sex Development, "Clinical Guidelines for the Management of Disorders of Sex Development in Childhood."
16. Speiser et al., "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency."
17. I.A. Hughes et al., "Consensus Statement on Management of Intersex Disorders, " Archives of Disease in Childhood 91, no. 7 (2006): 554-63.
18. M. Moody et al., "Surgery Considerations for Girls with Classical CAH, " CARES Foundation, http://www.caresfoundation.org/productcart/pc/surgery_considerations_cah.html#surgery, accessed September 21, 2012.
19. Speiser et al., "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency, " 4143.
20. Hughes et al., "Consensus Statement on Management of Intersex Disorders, " 557.
21. Moody et al., "Surgery Considerations for Girls with Classical CAH."
22. Consortium on the Management of Disorders of Sex Development, "Clinical Guidelines for the Management of Disorders of Sex Development in Childhood, " 3.
23. J. Frader et al., "Health Care Professionals and Intersex Conditions, " Archives of Pediatric and Adolescent Medicine 158, no. 5 (2004): 426-28.
24. J. Yang, D. Felsen, and D.P. Poppas, "Nerve Sparing Reduction Clitoroplasty: Analysis of Clitoral Sensitivity and Viability, " Journal of Urology 178, no. 4 (2007): 1598-1601.
25. A. Dreger and E.K. Feder, "Bad Vibrations, " Bioethics Forum, June 16, 2010, http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4730.
26. H. Rosin, "This Doctor Does What to 6-Year-Old Girls' Clitorises?" Slate, June 24, 2010, http://www.slate.com/id/2257987/
27. D. Savage, "Female Genital Mutilation at Cornell University, " Slog, June 16, 2010, http://slog.thestranger.com/slog/archives/2010/06/16/female-genital-mutilation-at-cornell-university.
28. Advocates for Informed Choice describes itself as an organization focused on legal advocacy for the rights of children with intersex conditions or DSDs ("differences of sex development"), http://aiclegal.org/about/, accessed October 1, 2012.
29. A. Tamar-Mattis, letter to Jerry Menikoff, director of Office for Human Research Protections, June 25, 2010, http://aiclegal.files.wordpress.com/2010/06/poppas-ohrp-letter.pdf.
30. M.C. Ristorucci, "Weill Medical College Says Poppas' Surgical Procedure Is Standard, " Cornell Daily Sun, October 5, 2010, http://cornellsun.com/node/43845.
31. Advocates for Informed Choice, "Poppas Update: Federal Agency Declines to Take Action on 'Clitoral Sensitivity Tests' on Children, " May 31, 2011, http://aiclegal.org/presscenter/update-federal-agency-declines-to-take-action-on-clitoral-sensitivity-tests-on-children/.
32. U.S. Department of Health and Human Services, 45 CFR 46.102.
33. S. Nimkarn and M.I. New, "Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency: A Paradigm for Prenatal Diagnosis and Treatment, " Annals of the New York Academy of Sciences 1192 (2010): 5-11.
34. M. Fernández-Balsells et al., "Prenatal Dexamethasone Use for the Prevention of Virilization in Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia Because of 21-Hydroxylase (CYP21A2) Deficiency: A Systematic Review and Meta-Analyses, " Clinical Endocrinology 73, no. 4 (2010): 436-44, at 438-39.
35. Speiser et al., "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency, " 4137.
36. H. Lindemann, E.K. Feder, and A. Dreger, "Fetal Cosmetology, " Bioethics Forum, February 8, 2010, http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4470#ixzz1hIiqdmYU.
37. Diamond et al., "Not Fetal Cosmetology." In a subsequent post, Dreger, Feder, and Lindemann thank Diamond et al. for pointing this out. They do not respond to or debate the claim that surgery to allow "normal urination and future sexual function" is medically necessary in childhood. A. Dreger, E. Feder, and H. Lindemann, "Prenatal Dex: Update and Omnibus Reply, " Bioethics Forum, March 18, 2010, http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4569&blogid=140.
38. These authors have also argued that dexamethasone treatment should not be administered at all to women at risk for carrying CAH-affected female fetuses, so presumably their position is that it should not be administered, but if it is administered, there should at least be an IRB involved and the possibility of collecting data on safety and efficacy.
39. E. Feder et al., "Letter of Concern from Bioethicists to FDA Office of Pediatric Therapeutics, the HHS Office for Human Research Protections and Others, " (undated), http://fetaldex.org/letter_bioethics.html, accessed October 1, 2012.
40. Fernández-Balsells et al., "Prenatal Dexamethasone Use for the Prevention of Virilization in Pregnancies at Risk for Classical Congenital Adrenal Hyperplasia because of 21-Hydroxylase (CYP21A2) Deficiency, " at 441 and 442.
41. Speiser et al., "Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency, " 4137.
42. Dreger, Feder, and Lindemann, "Prenatal Dex"; A. Dreger, E. Feder, and A. Tamar-Mattis, "Preventing Homosexuality (and Uppity Women) in the Womb?" Bioethics Forum, June 29, 2010, http://www.thehastingscenter.org/Bioethicsforum/Post.aspx?id=4754&blogid=140.
43. Nimkarn and New, "Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency, " 9.
44. M.I. New, "Psychologic Development after Early-Prenatal Dexamethasone Exposure Work Statement, " http://fetaldex.org/FOIA_files/12.97%20suppressing%20masculinization.pdf, accessed October 1, 2012; M.I. New, untitled document from a grant proposal, http://fetaldex.org/FOIA_files/12.97%20spectrum%20of%20behavioral%20effects%20-%20risks.pdf, accessed October 1, 2012.
45. Dreger, Feder, and Lindemann, "Prenatal Dex"; Dreger, Feder, and Tamar-Mattis, "Preventing Homosexuality (and Uppity Women) in the Womb?"
46. J. Lantos, "On Cultural Sanctions for Shaping our Children's Genitalia, " American Journal of Bioethics 10, no. 9 (2010): 55-57, at 56.
47. K.C. Borror, director, Division of Compliance Oversight, Office for Human Research Protections, letter to Ellen K. Feder and Alice Dreger, September 2, 2010, http://fetaldex.org/correspondence_files/OHRP_response_Sept_2_2010.pdf.
48. See "Bio-Thesiometer, " Bio-Medical Instrument Company, http://www.biothesiometer.com, accessed October 1, 2012.
49. M.C. Lu et al., "Provider Encouragement of Breast-Feeding: Evidence from a National Survey, " Obstetrics and Gynecology 97, no. 2 (2001): 290-95
50. A. Lustig and P. Scardino, "Elective Patients, " in Surgical Ethics, ed. L.B. McCullough, J.W. Jones, and B.A. Brody (New York: Oxford University Press, 1998)
51. W.E. Mouradian, "What's Special about the Surgical Context?" in Surgically Shaping Children: Technology, Ethics and the Pursuit of Normality, ed. E. Parens (Baltimore, Md.: Johns Hopkins University Press, 2006), 125-54.
52. "Support Dr. Poppas" Facebook page, https://www.facebook.com/group.php?gid=112890762105471#!/group.php?gid=112890762105471&v=wall, accessed October 1, 2012.
53. A.D. Dreger, "What to Expect When You Have the Child You Weren't Expecting, " in Surgically Shaping Children, ed. Parens, 253-66, at 261.
54. E. Feder, "In Their Best Interests: Parents' Experience of Atypical Genitalia, " in Surgically Shaping Children, ed. Parens, 189-210.
55. B.S. Wilfond et al., "Navigating Growth Attenuation in Children with Profound Disabilities: Children's Interests, Family Decision-Making, and Community Concerns, " Hastings Center Report 40, no. 6 (2010): 27-40.
56. H. Lindemann, "The Power of Parents and the Agency of Children, " in Surgically Shaping Children, ed. Parens, 176-88.
57. J. Hardwig, "What About the Family? The Role of Family Interests in Medical Decision Making, " Hastings Center Report 20, no. 2 (1990): 5-10.
58. A. Ouellette, "Eyes Wide Open: Surgery to Westernize the Eyes of an Asian Child, " Hastings Center Report 39, no. 1 (2009): 15-18.
59. C. Aspinall, "Do I Make You Uncomfortable?" in Surgically Shaping Children, ed. Parens, 13-28.
60. E. Parens, "Thinking about Surgically Shaping Children, " in Surgically Shaping Children, ed. Parens, xiii-xxx.
61. This view is explicitly endorsed by Dreger, Feder, and Tamar-Mattis in "Prenatal Dexamethasone for Congenital Adrenal Hyperplasia, " Journal of Bioethics Inquiry 9, no. 3 (2012): 277-94, at 279: "The problem we see in the use of prenatal dexamethasone for CAH.. is that.. [it] has sometimes been promoted.. for uses that are not legitimately medical."
62. Lisa Abelow Hedley talks about her concern that, as a parent of a child with achondroplasia contemplating elective surgery on her child's legs, she risks sending the message: "We love you, you're perfect the way you are.. now change." L.A. Hedley, "The Seduction of the Surgical Fix, " in Surgically Shaping Children, ed. Parens, 43-48, at 46.
63. "Support Dr. Poppas" Facebook page, https://www.facebook.com/group.php?gid=112890762105471#!/group.php?gid=112890762105471&v=wall, accessed October 1, 2012.
64. C.L. Minto et al., "The Effect of Clitoral Surgery on Sexual Outcome in Individuals Who Have Intersex Conditions with Ambiguous Genitalia: A Cross-Sectional Study, " Lancet 361 (2003): 1252-57
65. Crouch et al., "Sexual Function and Genital Sensitivity Following Feminizing Genitoplasty for Congenital Adrenal Hyperplasia."
66. A. Nordenskjöld et al., "Type of Mutation and Surgical Procedure Affect Long-Term Quality of Life for Women with Congenital Adrenal Hyperplasia, " Journal of Clinical Endocrinological Metabolism 93, no. 2 (2008): 380-86
67. A. Wisniewski et al., "Psychosexual Outcome in Women Affected by Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency, " Journal of Urology 171 (2004): 2497-2501.